The lastest cohort analysis. You can see the movement up in hospitalization case rates, but now that we know how many recent cases are breakthroughs and that a lot of hospitalizations in that group are not really for CV-19, and the same is likely true among unvaxed cases, I don’t know how real that is. Also is impacted by testing changes that identify fewer non-case cases. Slight uptick in death rate as well. More of Dave Dixon’s fine work.
